GeneDx Holdings ($WGS) Insider Trading & Smart Money Activity
GeneDx Holdings Corp. ($WGS) has 8 insider trades, 2 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($2.03M), net -$2.03M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$2.03M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 2
WGS insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $638.09K | 0 / 0 | 2 / 0 |
| Q3 2026 | 0 | 2 · $1.39M | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All WGS insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Stueland KatherineCHIEF EXECUTIVE OFFICER | Sell (Open-market sale) | 10.50K sh | $1.03M | -12.5% | -34.7% | — | ||||
| Insider | Feeley KevinCHIEF FINANCIAL OFFICER | Sell (Open-market sale) | 3.73K sh | $363.89K | -12.5% | -34.7% | — | ||||
| Analyst | Guggenheim | Reiterates to buy | PT $74 | -0.3% | -7.9% | Read | |||||
| Analyst | Piper Sandler | Reiterates to buy | PT $63 | +18.2% | +9.1% | Read | |||||
| Insider | Jason Ryan | Sell (Option exercise) | 3.58K sh | +16.4% | +2.8% | Read | |||||
| Insider | Joshua Ruch | Sell (Option exercise) | 3.58K sh | +16.4% | +2.8% | Read | |||||
| Insider | Joshua Ruch | Buy (Grant or award) | 4.25K sh | +16.4% | +2.8% | Read | |||||
| Insider | Eli Casdin | Buy (Grant or award) | 4.25K sh | +16.4% | +2.8% | Read | |||||
| Insider | Katherine StuelandCHIEF EXECUTIVE OFFICER | Sell (Open-market sale) | 10.50K sh | $638.09K | -4.2% | +1.8% | — | ||||
| Insider | Kevin FeeleyCHIEF FINANCIAL OFFICER | Sell (Option exercise) | 7.20K sh | -4.2% | +1.8% | Read | |||||
| 13F | ARK Investment Management | Added | +720.02K sh | $81.22M | +6.7% | +54.4% | Read | ||||
| 13F | ARK Investment Management | Added | +720.02K sh | $90.93M | +6.7% | +54.4% | Read |
1W / 1M / 6M = how WGS moved from the trade or filing date.
Insider trading in WGS: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Stueland Katherine | CHIEF EXECUTIVE OFFICER | 1 | -$1.03M | Sep 16, 2026 | |
| Feeley Kevin | CHIEF FINANCIAL OFFICER | 1 | -$363.89K | Sep 16, 2026 | |
| Joshua Ruch | 2 | — | Jun 18, 2026 | ||
| Jason Ryan | 1 | — | Jun 18, 2026 | ||
| Eli Casdin | 1 | — | Jun 18, 2026 | ||
| Katherine Stueland | CHIEF EXECUTIVE OFFICER | 1 | -$638.09K | Jun 16, 2026 | |
| Kevin Feeley | CHIEF FINANCIAL OFFICER | 1 | — | Jun 16, 2026 |
Institutions moving WGS (13F)
Analyst ratings on WGS
Frequently asked questions
Are WGS insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $2.03M, a net -$2.03M.
What is the latest insider trade in WGS?
Stueland Katherine, CHIEF EXECUTIVE OFFICER filed a sell (open-market sale) of 10.50K sh worth $1.03M on Sep 16, 2026.
Which institutions changed their WGS positions?
Recent 13F filers moving the stock include ARK Investment Management.
Other diagnostics & research stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.